ScholarIQanswers from OpenAlex

KDM5D epigenetically represses FERD3L to inhibit tumor growth in male colorectal cancer

PaperCitations, authors & open-access status

KDM5D epigenetically represses FERD3L to inhibit tumor growth in male colorectal cancer is a paper indexed in ScholarIQ from OpenAlex.

How many citations does KDM5D epigenetically represses FERD3L to inhibit tumor growth in male colorectal cancer have?

ScholarIQcitation count

KDM5D epigenetically represses FERD3L to inhibit tumor growth in male colorectal cancer has 0 citations in the OpenAlex counts ScholarIQ stores.

When was KDM5D epigenetically represses FERD3L to inhibit tumor growth in male colorectal cancer published?

ScholarIQyear

KDM5D epigenetically represses FERD3L to inhibit tumor growth in male colorectal cancer has 2026 year in the ScholarIQ index.

What is the open-access status of KDM5D epigenetically represses FERD3L to inhibit tumor growth in male colorectal cancer?

ScholarIQoa status

KDM5D epigenetically represses FERD3L to inhibit tumor growth in male colorectal cancer has closed oa status in the ScholarIQ index.

What is the DOI of KDM5D epigenetically represses FERD3L to inhibit tumor growth in male colorectal cancer?

ScholarIQdoi

The DOI for KDM5D epigenetically represses FERD3L to inhibit tumor growth in male colorectal cancer is on the source record.

What is the PMID of KDM5D epigenetically represses FERD3L to inhibit tumor growth in male colorectal cancer?

ScholarIQpmid

The PMID for KDM5D epigenetically represses FERD3L to inhibit tumor growth in male colorectal cancer is on the source record.

What is the OpenAlex record for KDM5D epigenetically represses FERD3L to inhibit tumor growth in male colorectal cancer?

ScholarIQopenalex

The OpenAlex for KDM5D epigenetically represses FERD3L to inhibit tumor growth in male colorectal cancer is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial